MOLN Competitors & Alternatives
Compare Molecular Partners AG ADR with similar stocks in the same industry
Biotechnology
MOLN
Main Stock$3.80
Tradestie Score
51
Market Cap
$138.88M
Revenue Growth
-1.0%
Analyst Upside
+192.2%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CABA
Cabaletta Bio, Inc. Common Stock
|
$3.29
|
$211.28M | - | 54 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$7.29
|
$211.22M | - | 63 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.40
|
$202.58M | - | 52 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$18.55
|
$199.71M | - | 51 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$16.16
|
$170.45M | - | 49 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$4.77
|
$158.43M | - | 62 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$9.88
|
$133.50M | - | 47 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.80
|
$110.20M | - | 54 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$34.48
|
$76.55M | - | 53 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.34
|
$71.69M | - | 55 | Compare |
More MOLN Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2836)
227 stocks in this industry